IBO
Impact Biomedical Inc
AMEX · Pharmaceuticals
$0.47
-0.01 (-2.98%)
Open$0.46
Previous Close$0.49
Day High$0.50
Day Low$0.46
52W High$23.68
52W Low$15.25
Volume—
Avg Volume634.0K
Market Cap5.75M
P/E Ratio—
EPS$-1.86
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.01M | 2.09M | 2.10M |
| Net Income | 252.5K | 255.6K | 224.6K |
| Profit Margin | 12.5% | 12.2% | 10.7% |
| EBITDA | 413.4K | 402.4K | 414.7K |
| Free Cash Flow | 302.8K | 206.2K | 229.1K |
| Rev Growth | +12.9% | +6.5% | +8.3% |
| Debt/Equity | 0.52 | 0.58 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |